Evidence map›Paper›PMID 40107660›Full record

SynthesisEuropean respiratory review : an official journal of the European Respiratory Society2025

Remote monitoring in asthma: a systematic review.

Giselle Mosnaim, Michelle Carrasquel, Tatum Ewing, Alba Berty, Madeline Snedden

Abstract readSystematic Review
In one paragraph

Synthesis in European respiratory review : an official journal of the European Respiratory Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Giselle MosnaimDivision of Allergy and Immunology, Department of Medicine, Endeavor Health, Evanston, IL, USA gmosnaim@northshore.org.
Michelle CarrasquelDivision of Allergy and Immunology, Department of Medicine, Endeavor Health, Evanston, IL, USA.
Tatum EwingDivision of Allergy and Immunology, Department of Medicine, Endeavor Health, Evanston, IL, USA.
Alba BertyDivision of Allergy and Immunology, Department of Medicine, Endeavor Health, Evanston, IL, USA.
Madeline SneddenDivision of Allergy and Immunology, Department of Medicine, Endeavor Health, Evanston, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoor adherence to maintenance inhalers and incorrect maintenance and reliever inhaler technique are associated with poor asthma outcomes. Remote therapeutic monitoring and remote patient monitoring support asthma guideline recommendations to regularly review adherence and inhaler technique, with the ultimate goal to improve asthma outcomes.

objectiveThis work systematically reviewed all clinical trials testing remote monitoring interventions on asthma outcomes.

methodsA systematic search of PubMed, SCOPUS, Ovid, CINAHL and reference review databases was conducted from 1 January 2000 to 30 April 2024. Articles were included if the title or abstract included MeSH terms of "nebulizers and vaporizers" in combination with "digital", "remote", "electronic" or "smart inhaler" to identify interventional studies testing remote monitoring for asthma. We characterised populations, interventions, control groups, outcomes, timeframe and setting across studies.

resultsOf 2043 articles reviewed, 19 articles met the inclusion criteria (n=14 remote therapeutic monitoring; n=5 remote patient monitoring). While a wide range of outcomes were measured across studies, overall, the studies (n=19) that met the inclusion criteria demonstrated a slower decline in maintenance inhaler adherence (n=13), decreased reliever use (n=6) and improvements in asthma control (n=3). They did not demonstrate positive outcomes on asthma exacerbations and healthcare utilisation, but this may be due to study sample sizes, eligibility criteria and duration.

conclusionRemote monitoring demonstrates improvements in important intermediary asthma outcomes. Future studies with larger sample sizes, duration and requiring greater disease severity as eligibility criteria are warranted to evaluate their efficacy at decreasing asthma-related oral steroid use, emergency department visits, hospitalisations and costs.

Indexed as

Anti-Asthmatic AgentsAsthmaLungAdministration, InhalationHumansMedication AdherenceNebulizers and VaporizersRemote Sensing TechnologyTelemedicineTreatment OutcomeAnti-Asthmatic Agents

Identifiers

PMID40107660
PMCPMC11920888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.